Oral Screening

Through a strategic alliance with Avitar, Inc., we offer ORALscreenTM 4, the world's first oral fluid point-of-collection drugs-of-abuse system for detecting marijuana (THC), cocaine, opiates, methamphetamine and MDMA, also known as Ecstasy. A highly sensitive, simple-to-use, reliable, portable drug test, ORALscreen detects the presence of specific illegal substances within minutes. Answering the increasing demand of faster yet accurate results, the procedure is quick and is collected under readily observable conditions, on-site and on-demand, making it nearly impossible to contaminate test results.

According to the 1998 National Household Survey on Drug Abuse published by SAMHSA (the Substance Abuse and Mental Health Services Administration), nearly 73 percent of all illegal drug users in the United States are employed. Lost productivity, high employee turnover, low employee morale, mistakes and accidents, and increased workers' compensation insurance and health insurance premiums are all results of untreated substance abuse problems in the workplace costing U.S. companies an estimated $100 billion per year.

Most Fortune 1000 corporations have established drug screening programs, however, the majority of small to medium-sized businesses, which employ about 80 percent of all U.S. workers, do not. ORALscreen 4 makes drug screening affordable, allowing all businesses, no matter their size, to provide safe and healthy work environments.